# OpenAI Unveils Specialized AI Model for Protein Engineering Breakthrough

OpenAI announced a new specialized AI model called GPT-4b micro that is accelerating breakthroughs in life sciences research, particularly in protein engineering for medical applications.

The company revealed that this focused AI tool has already demonstrated real-world impact through a collaboration with Retro Bio, a biotechnology firm. Together, they successfully engineered more effective proteins specifically designed for stem cell therapy and longevity research.

This development marks a significant shift in how AI is being applied to biological research. Rather than using general-purpose AI models, GPT-4b micro represents a specialized approach tailored for the complex challenges of protein design—a field where small improvements can lead to major therapeutic advances.

**Why it matters:** Protein engineering is fundamental to developing new treatments for diseases and age-related conditions. Traditional methods of designing proteins can take years of trial and error.